Skip to main content

Autism Spectrum Disorders

3
Pipeline Programs
10
Companies
11
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

9 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
5 programs
1
1
Double blind phase Placebo Nasal SprayPhase 21 trial
OxytocinPhase 11 trial
Computerized executive control trainingN/A1 trial
Coping Effectiveness TrainingN/A1 trial
Patient NavigationN/A
Active Trials
NCT02361762Completed70Est. Nov 2017
NCT01168284Completed30Est. May 2011
NCT01945957Completed33Est. Jan 2017
+1 more trials
Spine BioPharma
Spine BioPharmaNY - New York
1 program
1
Autologous bone marrow mononuclear cell transplantationPhase 11 trial
Active Trials
NCT01974973Withdrawn0Est. May 2016
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
2 programs
ESI - Community OutreachN/A1 trial
Personalized Cognitive-behavioral therapyN/A1 trial
Active Trials
NCT01250938Completed44Est. May 2019
NCT02028247Completed214Est. Oct 2018
Genome & Company
Genome & CompanyKorea - Suwon
1 program
Coping Effectiveness TrainingN/A
Alliance Pharmaceuticals
1 program
Intranasal OxytocinN/A1 trial
Active Trials
NCT01337687Completed19Est. Dec 2013
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Novel Measure of Social Deficits in ChildrenN/A1 trial
Active Trials
NCT02035176Completed92Est. Dec 2018
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Patient NavigationN/A1 trial
Active Trials
NCT02374541Completed305Est. Nov 2018
Temple Therapeutics
Temple TherapeuticsNetherlands - Geleen
1 program
Personalized Cognitive-behavioral therapyN/A
Jerusalem Pharmaceuticals
Jerusalem PharmaceuticalsIsrael - Ramallah
1 program
The Development of Younger Siblings of Children With Autism Now at 10 Years of AgeN/A1 trial
Active Trials
NCT00695812Unknown104Est. Sep 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Human BioSciencesDouble blind phase Placebo Nasal Spray
Human BioSciencesOxytocin
Spine BioPharmaAutologous bone marrow mononuclear cell transplantation
Colorado TherapeuticsPatient Navigation
Human BioSciencesComputerized executive control training
Angeles TherapeuticsPersonalized Cognitive-behavioral therapy
Oregon TherapeuticsNovel Measure of Social Deficits in Children
Human BioSciencesCoping Effectiveness Training
Alliance PharmaceuticalsIntranasal Oxytocin
Angeles TherapeuticsESI - Community Outreach
Jerusalem PharmaceuticalsThe Development of Younger Siblings of Children With Autism Now at 10 Years of Age

Clinical Trials (11)

Total enrollment: 1,201 patients across 11 trials

NCT01944046Human BioSciencesDouble blind phase Placebo Nasal Spray

Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors

Start: Aug 2014Est. completion: Nov 2017290 patients
Phase 2Completed
NCT01945957Human BioSciencesOxytocin

Brain Imaging of Intranasal Oxytocin Treatment in Autism

Start: Sep 2014Est. completion: Jan 201733 patients
Phase 1Completed
NCT01974973Spine BioPharmaAutologous bone marrow mononuclear cell transplantation

Stem Cell Therapy in Autism Spectrum Disorders

Start: Aug 2009Est. completion: May 20160
Phase 1Withdrawn
NCT02374541Colorado TherapeuticsPatient Navigation

Screening and Linkage to Services for Autism

Start: Feb 2015Est. completion: Nov 2018305 patients
N/ACompleted
NCT02361762Human BioSciencesComputerized executive control training

Gaming for Autism to Mold Executive Skills Project

Start: Feb 2015Est. completion: Nov 201770 patients
N/ACompleted
NCT02028247Angeles TherapeuticsPersonalized Cognitive-behavioral therapy

Psychotherapy for Anxiety in Children With Autism Spectrum Disorder

Start: Apr 2014Est. completion: Oct 2018214 patients
N/ACompleted
NCT02035176Oregon TherapeuticsNovel Measure of Social Deficits in Children

Novel Measure of Social Deficits in Children

Start: Feb 2014Est. completion: Dec 201892 patients
N/ACompleted
NCT01168284Human BioSciencesCoping Effectiveness Training

A Coping Effectiveness Training Intervention for Caregivers of Children With Autism Spectrum: A Feasibility Study

Start: Jul 2010Est. completion: May 201130 patients
N/ACompleted
NCT01337687Alliance PharmaceuticalsIntranasal Oxytocin

Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders

Start: Oct 2009Est. completion: Dec 201319 patients
N/ACompleted
NCT01250938Angeles TherapeuticsESI - Community Outreach

Effectiveness of Early Intervention in an Underserved Population

Start: Jul 2009Est. completion: May 201944 patients
N/ACompleted
NCT00695812Jerusalem PharmaceuticalsThe Development of Younger Siblings of Children With Autism Now at 10 Years of Age

The Development of Younger Siblings of Children With Autism Now at 10 Years of Age

Start: Sep 2008Est. completion: Sep 2011104 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

10 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.